US Stock MarketDetailed Quotes

CLX Clorox

Watchlist
  • 134.760
  • +1.350+1.01%
Trading May 15 11:37 ET
16.61BMarket Cap24.19P/E (TTM)

Clorox Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
Total revenue
-8.05%1.67B
-15.28%1.69B
27.13%1.76B
-4.01%7.09B
-5.75%1.9B
-5.27%1.81B
16.03%1.99B
-20.34%1.39B
3.97%7.39B
12.10%2.02B
Operating revenue
-8.05%1.67B
-15.28%1.69B
27.13%1.76B
-4.01%7.09B
-5.75%1.9B
-5.27%1.81B
16.03%1.99B
-20.34%1.39B
3.97%7.39B
12.10%2.02B
Cost of revenue
-11.83%924M
-15.66%948M
11.83%955M
-9.73%4.05B
-11.93%1.02B
-6.01%1.05B
2.65%1.12B
-23.34%854M
-1.78%4.48B
2.12%1.16B
Gross profit
-2.87%744M
-14.78%738M
51.69%807M
4.81%3.05B
2.55%884M
-4.25%766M
39.68%866M
-15.02%532M
14.26%2.91B
29.04%862M
Operating expense
-8.83%506M
-29.39%507M
9.15%513M
11.51%2.33B
-5.59%574M
0.54%555M
52.44%718M
3.52%470M
14.18%2.09B
17.83%608M
Selling and administrative expenses
-8.14%474M
-30.63%471M
9.30%482M
13.20%2.17B
-1.11%534M
-0.19%516M
55.02%679M
4.50%441M
15.27%1.92B
19.73%540M
-Selling and marketing expense
-3.72%207M
2.69%191M
21.82%201M
13.35%832M
26.07%266M
4.37%215M
19.23%186M
2.48%165M
3.53%734M
1.93%211M
-General and administrative expense
-11.30%267M
-43.20%280M
1.81%281M
13.10%1.34B
-18.54%268M
-3.22%301M
74.82%493M
5.75%276M
24.00%1.18B
34.84%329M
Research and development costs
-15.63%27M
-3.13%31M
6.90%31M
-8.70%126M
-13.16%33M
-8.57%32M
-3.03%32M
-9.38%29M
4.55%138M
11.76%38M
Depreciation amortization depletion
-28.57%5M
-28.57%5M
----
-3.33%29M
--7M
--7M
--7M
----
-3.23%30M
----
-Depreciation and amortization
-28.57%5M
-28.57%5M
----
-3.33%29M
--7M
--7M
--7M
----
-3.23%30M
----
Operating profit
12.80%238M
56.08%231M
374.19%294M
-12.15%723M
22.05%310M
-14.92%211M
-0.67%148M
-63.95%62M
14.46%823M
67.11%254M
Net non-operating interest income expense
-16.67%-21M
-5.26%-20M
0.00%-21M
9.46%-67M
-280.00%-19M
25.00%-18M
17.39%-19M
4.55%-21M
26.73%-74M
84.38%-5M
Non-operating interest income
-50.00%2M
-71.43%2M
----
43.75%23M
--2M
--4M
--7M
----
220.00%16M
----
Non-operating interest expense
4.55%23M
-15.38%22M
0.00%21M
0.00%90M
0.00%21M
-8.33%22M
13.04%26M
-4.55%21M
-15.09%90M
-43.24%21M
Other net income (expense)
115.74%37M
271.43%26M
-700.00%-96M
49.51%-258M
-33.33%-16M
49.89%-235M
75.00%7M
64.71%-12M
-4,545.45%-511M
-233.33%-12M
Gain on sale of security
-114.29%-1M
0.00%-3M
----
-600.00%-5M
--1M
--7M
---3M
----
104.17%1M
----
Earnings from equity interest
--0
0.00%1M
----
25.00%5M
--2M
--1M
--1M
----
-33.33%4M
----
Special income (charges)
--0
43.75%23M
---118M
51.71%-240M
78.85%-11M
44.94%-245M
--16M
--0
-3,650.00%-497M
-471.43%-52M
-Less：Restructuring and merger&acquisition
--0
----
----
-69.23%16M
--11M
--5M
----
----
--52M
----
-Less:Impairment of capital assets
----
----
----
--0
--0
--0
----
----
--445M
--0
-Less:Other special charges
----
---23M
----
----
----
----
----
----
----
----
-Gain on sale of business
--0
--0
---118M
---240M
--0
---240M
--0
--0
--0
--0
-Gain on sale of property,plant,equipment
--0
--0
----
--16M
--0
--0
--16M
----
--0
----
Other non- operating income (expenses)
1,800.00%38M
171.43%5M
283.33%22M
5.26%-18M
-122.86%-8M
108.33%2M
-275.00%-7M
64.71%-12M
-171.43%-19M
169.23%35M
Income before tax
704.76%254M
74.26%237M
510.34%177M
67.23%398M
16.03%275M
82.86%-42M
4.62%136M
-75.00%29M
-60.79%238M
83.72%237M
Income tax
687.50%63M
7.50%43M
1,750.00%74M
37.66%106M
-3.57%54M
122.22%8M
42.86%40M
-86.21%4M
-43.38%77M
124.00%56M
Net income
482.00%191M
102.08%194M
312.00%103M
81.37%292M
22.10%221M
76.08%-50M
-5.88%96M
-71.26%25M
-65.82%161M
74.04%181M
Net income continuous Operations
482.00%191M
102.08%194M
312.00%103M
81.37%292M
22.10%221M
76.08%-50M
-5.88%96M
-71.26%25M
-65.82%161M
74.04%181M
Minority interest income
400.00%5M
-66.67%1M
33.33%4M
0.00%12M
0.00%5M
-50.00%1M
0.00%3M
50.00%3M
33.33%12M
66.67%5M
Net income attributable to the parent company
464.71%186M
107.53%193M
350.00%99M
87.92%280M
22.73%216M
75.83%-51M
-6.06%93M
-74.12%22M
-67.75%149M
74.26%176M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
464.71%186M
107.53%193M
350.00%99M
87.92%280M
22.73%216M
75.83%-51M
-6.06%93M
-74.12%22M
-67.75%149M
74.26%176M
Basic earnings per share
468.29%1.51
106.67%1.55
370.59%0.8
86.78%2.26
21.68%1.74
76.02%-0.41
-7.41%0.75
-75.36%0.17
-67.73%1.21
76.54%1.43
Diluted earnings per share
465.85%1.5
105.33%1.54
370.59%0.8
87.50%2.25
21.83%1.73
76.02%-0.41
-6.25%0.75
-75.00%0.17
-67.83%1.2
75.31%1.42
Dividend per share
1.67%1.22
1.67%1.22
1.67%1.22
1.69%4.8
1.69%1.2
1.69%1.2
1.69%1.2
1.69%1.2
1.72%4.72
1.72%1.18
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023
Total revenue -8.05%1.67B-15.28%1.69B27.13%1.76B-4.01%7.09B-5.75%1.9B-5.27%1.81B16.03%1.99B-20.34%1.39B3.97%7.39B12.10%2.02B
Operating revenue -8.05%1.67B-15.28%1.69B27.13%1.76B-4.01%7.09B-5.75%1.9B-5.27%1.81B16.03%1.99B-20.34%1.39B3.97%7.39B12.10%2.02B
Cost of revenue -11.83%924M-15.66%948M11.83%955M-9.73%4.05B-11.93%1.02B-6.01%1.05B2.65%1.12B-23.34%854M-1.78%4.48B2.12%1.16B
Gross profit -2.87%744M-14.78%738M51.69%807M4.81%3.05B2.55%884M-4.25%766M39.68%866M-15.02%532M14.26%2.91B29.04%862M
Operating expense -8.83%506M-29.39%507M9.15%513M11.51%2.33B-5.59%574M0.54%555M52.44%718M3.52%470M14.18%2.09B17.83%608M
Selling and administrative expenses -8.14%474M-30.63%471M9.30%482M13.20%2.17B-1.11%534M-0.19%516M55.02%679M4.50%441M15.27%1.92B19.73%540M
-Selling and marketing expense -3.72%207M2.69%191M21.82%201M13.35%832M26.07%266M4.37%215M19.23%186M2.48%165M3.53%734M1.93%211M
-General and administrative expense -11.30%267M-43.20%280M1.81%281M13.10%1.34B-18.54%268M-3.22%301M74.82%493M5.75%276M24.00%1.18B34.84%329M
Research and development costs -15.63%27M-3.13%31M6.90%31M-8.70%126M-13.16%33M-8.57%32M-3.03%32M-9.38%29M4.55%138M11.76%38M
Depreciation amortization depletion -28.57%5M-28.57%5M-----3.33%29M--7M--7M--7M-----3.23%30M----
-Depreciation and amortization -28.57%5M-28.57%5M-----3.33%29M--7M--7M--7M-----3.23%30M----
Operating profit 12.80%238M56.08%231M374.19%294M-12.15%723M22.05%310M-14.92%211M-0.67%148M-63.95%62M14.46%823M67.11%254M
Net non-operating interest income expense -16.67%-21M-5.26%-20M0.00%-21M9.46%-67M-280.00%-19M25.00%-18M17.39%-19M4.55%-21M26.73%-74M84.38%-5M
Non-operating interest income -50.00%2M-71.43%2M----43.75%23M--2M--4M--7M----220.00%16M----
Non-operating interest expense 4.55%23M-15.38%22M0.00%21M0.00%90M0.00%21M-8.33%22M13.04%26M-4.55%21M-15.09%90M-43.24%21M
Other net income (expense) 115.74%37M271.43%26M-700.00%-96M49.51%-258M-33.33%-16M49.89%-235M75.00%7M64.71%-12M-4,545.45%-511M-233.33%-12M
Gain on sale of security -114.29%-1M0.00%-3M-----600.00%-5M--1M--7M---3M----104.17%1M----
Earnings from equity interest --00.00%1M----25.00%5M--2M--1M--1M-----33.33%4M----
Special income (charges) --043.75%23M---118M51.71%-240M78.85%-11M44.94%-245M--16M--0-3,650.00%-497M-471.43%-52M
-Less：Restructuring and merger&acquisition --0---------69.23%16M--11M--5M----------52M----
-Less:Impairment of capital assets --------------0--0--0----------445M--0
-Less:Other special charges -------23M--------------------------------
-Gain on sale of business --0--0---118M---240M--0---240M--0--0--0--0
-Gain on sale of property,plant,equipment --0--0------16M--0--0--16M------0----
Other non- operating income (expenses) 1,800.00%38M171.43%5M283.33%22M5.26%-18M-122.86%-8M108.33%2M-275.00%-7M64.71%-12M-171.43%-19M169.23%35M
Income before tax 704.76%254M74.26%237M510.34%177M67.23%398M16.03%275M82.86%-42M4.62%136M-75.00%29M-60.79%238M83.72%237M
Income tax 687.50%63M7.50%43M1,750.00%74M37.66%106M-3.57%54M122.22%8M42.86%40M-86.21%4M-43.38%77M124.00%56M
Net income 482.00%191M102.08%194M312.00%103M81.37%292M22.10%221M76.08%-50M-5.88%96M-71.26%25M-65.82%161M74.04%181M
Net income continuous Operations 482.00%191M102.08%194M312.00%103M81.37%292M22.10%221M76.08%-50M-5.88%96M-71.26%25M-65.82%161M74.04%181M
Minority interest income 400.00%5M-66.67%1M33.33%4M0.00%12M0.00%5M-50.00%1M0.00%3M50.00%3M33.33%12M66.67%5M
Net income attributable to the parent company 464.71%186M107.53%193M350.00%99M87.92%280M22.73%216M75.83%-51M-6.06%93M-74.12%22M-67.75%149M74.26%176M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 464.71%186M107.53%193M350.00%99M87.92%280M22.73%216M75.83%-51M-6.06%93M-74.12%22M-67.75%149M74.26%176M
Basic earnings per share 468.29%1.51106.67%1.55370.59%0.886.78%2.2621.68%1.7476.02%-0.41-7.41%0.75-75.36%0.17-67.73%1.2176.54%1.43
Diluted earnings per share 465.85%1.5105.33%1.54370.59%0.887.50%2.2521.83%1.7376.02%-0.41-6.25%0.75-75.00%0.17-67.83%1.275.31%1.42
Dividend per share 1.67%1.221.67%1.221.67%1.221.69%4.81.69%1.21.69%1.21.69%1.21.69%1.21.72%4.721.72%1.18
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Halozyme Therapeutics
HALO
49.375
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.320
eBay
EBAY
70.730
4
YETI Holdings
YETI
31.960
5
Collegium Pharmaceutical
COLL
29.550
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.